文献速递眼底病与葡萄膜炎

小鼠玻璃体腔注射腺相关病毒后基因治疗相关葡萄膜炎的特征

Characterization of Gene Therapy Associated Uveitis Following Intravitreal Adeno-Associated Virus Injection in Mice.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

该研究向AAV初治和AAV预免疫的C57Bl/6小鼠玻璃体腔注射表达绿色荧光蛋白的AAV载体,用OCT评估临床炎症并用流式细胞术定量眼内免疫细胞。结果显示注射眼OCT炎症评分和CD45+细胞数显著升高,临床可见的玻璃体炎在第7天达峰并于第29天消退,但细胞炎症持续至第29天。

要点

  • 玻璃体腔AAV注射可引起小鼠轻度临床炎症,OCT玻璃体炎约第7天达峰、第29天消退。
  • CD45+细胞总数在注射眼显著升高并持续至第29天,第29天以CD8- T细胞为主。
  • 先天和适应性免疫细胞均对AAV应答,但AAV初治眼的适应性应答延迟。

核心结论

  • 小鼠玻璃体腔AAV注射产生的临床可见炎症较轻且似乎可自行消退。
  • 但眼内CD45+细胞总数特别是T细胞持续升高。

研究设计与样本

  • 将携带PR2.1控制表达绿色荧光蛋白质粒的AAV载体注射到AAV初治和AAV预免疫的C57Bl/6小鼠玻璃体腔。
  • 用OCT评估临床炎症,并在注射后第1、7、29天用流式细胞术鉴定和定量眼内免疫细胞群,与假注射眼和对侧眼对照比较。

主要发现

  • AAV注射眼的OCT炎症评分和总CD45+细胞数显著高于未注射对侧眼和假注射对照。
  • AAV注射眼的临床可见炎症(OCT玻璃体炎)和细胞炎症(CD45+细胞数)显著增加,约在第7天达峰。
  • 玻璃体炎第29天消退,但细胞炎症持续至第29天。
  • 第1天,所有AAV注射眼以中性粒细胞和活化单核细胞为主。
  • 第7天,AAV暴露动物眼内的树突状细胞和T细胞显著多于AAV初治动物眼;第29天,CD8- T细胞是AAV注射眼CD45+细胞群的主体。

临床怎么用

  • 解读玻璃体腔AAV基因治疗的炎症表现时,需注意临床炎症消退后细胞炎症仍可能持续。
  • 评估AAV眼内免疫反应时应兼顾先天与适应性免疫,并考虑既往AAV暴露状态对适应性应答时相的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To characterize the intraocular immune cell infiltrate induced by intravitreal adeno-associated virus (AAV) gene therapy. METHODS: AAV vectors carrying plasmids expressing green fluorescent protein under the control of PR2.1 were injected intravitreally into AAV naive and AAV primed C57Bl/6 mice. Clinical inflammation was assessed using optical coherence tomography. Intraocular immune cell populations were identified and quantified by flow cytometry on days 1, 7, and 29 after intravitreal injection and compared with sham and fellow eye controls. RESULTS: Optical coherence tomography inflammation score and total CD45+ cell number were significantly higher in AAV injected eyes compared to uninjected fellow eye and sham injected controls. Clinically apparent inflammation (vitritis on optical coherence tomography) and cellular inflammation (CD45+ cell number) was significantly increased in AAV injected eyes and peaked around day 7. Vitritis resolved by day 29, but cellular inflammation persisted through day 29. On day 1, neutrophils and activated monocytes were the dominant cell populations in all AAV injected eyes. On day 7, eyes of AAV exposed animals had significantly more dendritic cells and T cells than eyes of AAV naive animals. By day 29, CD8- T cells were the dominant CD45+ cell population in AAV injected eyes. CONCLUSIONS: Intravitreal AAV injection in mice generates clinically evident inflammation that is mild and seems to resolve spontaneously. However, the total number of intraocular CD45+ cells, particularly T cells, remain elevated. Both innate and adaptive immune cells respond to intravitreal AAV regardless of prior immune status, but the adaptive response is delayed in AAV naive eyes.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Tummala G, Crain A, Rowlan J, et al. Characterization of Gene Therapy Associated Uveitis Following Intravitreal Adeno-Associated Virus Injection in Mice. Invest Ophthalmol Vis Sci. 2021. PMID: 33630023. doi:10.1167/iovs.62.2.41

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。